EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma

Yura Seo iD, Yoon Dae Han, Linda Bojmar iD, Kyung-A Kim, Yurin Seo, Taeyul K Kim, Suho Lee, Yeleem Kim, Hye Bin Choi, Yujin H Lim, Chae Hyun Kim, Alexander Sandberg und 22 weitere

Journal of Extracellular Vesicles · 2026

DOI: 10.1002/jev2.70278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2026. Verfasst von Yura Seo und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomarkers, Tumor, Colonic Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Industry Development Institute, NIGMS NIH HHS, National Research Foundation of Korea (NRF) grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of colon adenocarcinoma (COAD) remains suboptimal. Fecal tests fail to diagnose 30% of stage I cancer, and serum CEA lacks sensitivity (< 40%). Extracellular vesicles (EVs) circulate systemically and package tumor‐related cargo, making them attractive non‐invasive biomarkers for cancer diagnosis. We profiled the EV proteome from 233 human patients using LC‐MS/MS, including stage I‑IV tumors with matched non‑tumor colon tissues ( n = 50 each; n = 100), paired pre‑/post‑operative plasma ( n = 90) and healthy plasma ( n = 43). Circulating EVs contained both tumor‐specific and stromal/immune cell‐derived proteins, reflecting the systemic nature of EV biology in the cancer setting. Proteomic analysis identified 745 proteins enriched in tumor‐derived EVs (e.g., SRPK1, THBS2) and 127 proteins enriched in adjacent tissues. Plasma EVs revealed 166 proteins enriched in COAD (e.g., UBA1, FCN1) and 233 enriched in healthy controls. Pathway analysis linked tumor EV cargo to angiogenesis, mRNA splicing, TGF‑ β signalling and RNA translation. Notably, a cross‐cancer comparison (pancreatic = 10, lung = 14 cases) revealed that 76% of tumor EV proteins were COAD‐specific, highlighting tissue of origin specificity. We further developed a 10‐protein EV panel comprising seven tumor‐associated and three healthy‐enriched EV proteins, which effectively distinguished COAD patients from healthy controls in the two validation cohorts ( n = 104 and n = 215), achieving > 90% sensitivity for differentiating COAD from healthy and non‐COAD colorectal conditions. Six weeks after curative resection, tumor‐associated EV proteins decreased by > 70%, whereas healthy‐associated proteins rebounded to baseline, indicating surgical responsiveness. Collectively, EV protein signatures provide a sensitive and tissue‐specific window into tumor–host communication, further supporting blood‐based early detection of COAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesBiomarkers, TumorColonic NeoplasmsAdenocarcinomaProteomicsHumansFemaleMaleMiddle AgedAgedProteomeTandem Mass Spectrometry

Substanzen

Biomarkers, TumorProteome

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Graduate School of Medical Science, Brain Korea 21 FOUR Project, Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Division of Colorectal Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, New Yor…
  • Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
  • Proteomics Resource Center, The Rockefeller University, New York, New York, USA.

ORCID-Profile: Yura Seo, Linda Bojmar, Hyo-Il Jung, Han Sang Kim

Förderung

  • Korea Health Industry Development Institute
  • NIGMS NIH HHS
  • National Research Foundation of Korea (NRF) grants
  • Yonsei University College of Medicine

Zitieren

APA

Seo, Y., Han, Y. D., Bojmar, L., Kim, K. A., Seo, Y., Kim, T. K., Lee, S., Kim, Y., Choi, H. B., Lim, Y. H., Kim, C. H., Sandberg, A., Fan, C., Lauritzen, P., Molina, H., Peralta, C., Geri, J. B., Burdette, C., Han, D. H., …, & Kim, H. S. (2026). Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70278

Vancouver

Seo Y, Han YD, Bojmar L, Kim KA, Seo Y, Kim TK, et al. Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma. Journal of Extracellular Vesicles. 2026. doi:10.1002/jev2.70278

BibTeX
@article{Seo2026,
  author = {Seo, Yura and Han, Yoon Dae and Bojmar, Linda and Kim, Kyung-A and Seo, Yurin and Kim, Taeyul K and Lee, Suho and Kim, Yeleem and Choi, Hye Bin and Lim, Yujin H and Kim, Chae Hyun and Sandberg, Alexander and Fan, Chuanwen and Lauritzen, Pernille and Molina, Henrik and Peralta, Christopher and Geri, Jacob B and Burdette, Colin and Han, Dai Hoon and Gee, Heon Yung and Lee, Insuk and Shin, Jeon-Soo and Kim, Hyunwook and Li, Leon and Tobias, Gabriel C and Wortzel, Inbal and Shin, Sang Joon and Jung, Hyo-Il and Lee, Min Goo and Paik, Soonmyung and Schwartz, Robert E and Ahn, Joong Bae and Lyden, David and Kim, Han Sang},
  title = {Proteomic Profiling of Human Extracellular Vesicles Reveals Diagnostic Biomarkers for Colon Adenocarcinoma},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  doi = {10.1002/jev2.70278}
}
Kostenlos starten →